Work

184eP Impact of bronchiectasis in lung cancer chemotherapy

Year: 2026

Type: article

Abstract: Lung cancer remains the leading cause of cancer-related mortality worldwide, and many patients present with advanced disease requiring systemic chemotherapy. Treatment tolerance and outcomes may be influenced by coexisting respiratory comorbidities. Bronchiectasis (BE), a chronic airway disease characterized by persistent inflammation and recurrent infection, is increasingly recognized among lung cancer patients; however, its clinical impact during chemotherapy remains unclear.

Source: ESMO Open

DOI: 10.1016/j.esmoop.2026.106491

Authors: H. Kang, J. Kim

Institution: Hallym University Dongtan Sacred Heart Hospital

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910